April 20, 2026 — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today marked 4/20 by reinforcing its leadership in medical cannabis and its commitment to advancing patient care through a science-driven global platform.
Irwin D. Simon, Chairman and Chief Executive Officer, stated:
“4/20 reflects how far this industry has evolved, from an emerging category into a global opportunity grounded in science, innovation, and patient impact. At Tilray, we’ve built a diversified international platform designed to lead that evolution.
Today, we serve hundreds of thousands of patients worldwide with pharmaceutical-grade medical cannabis products that meet the highest standards of quality, consistency, and safety. Our focus is clear: advancing a medical-first, science-driven approach that supports patients, physicians, and healthcare systems globally.
As regulatory frameworks progress, including the significant opportunity ahead in the United States, Tilray is uniquely positioned with the infrastructure, expertise, and credibility to lead the next phase of growth.”
As a cannabis leader in Canada, Tilray holds a leading position across both adult-use and medical markets, supported by a strong portfolio of trusted brands, scaled operations, and deep regulatory expertise.
Tilray Medical offers more than 150 medical cannabis products internationally and has supported over 400,000 patients globally. The Company continues to invest in clinical research, physician education, and pharmaceutical distribution to expand access to safe, consistent treatment options.
With operations across multiple continents, Tilray’s integrated model, spanning pharmaceutical-grade cultivation, production, clinical services, and distribution, positions the Company to scale a fully connected, patient-centric global platform.
Tilray remains focused on disciplined execution, advancing innovation, and expanding access to high-quality care as the global medical cannabis market continues to evolve.
About Tilray Brands
Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.
